• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form EFFECT filed by Processa Pharmaceuticals Inc.

    6/18/25 12:15:17 AM ET
    $PCSA
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $PCSA alert in real time by email
    Notice of Effectiveness
    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    Notice of Effectiveness
    Effectiveness Date: June 17, 2025 12:00 P.M.
    Form: S-1
    CIK: 0001533743
    Company Name: Processa Pharmaceuticals, Inc.
    File Number: 333-287997
    Get the next $PCSA alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $PCSA

    DatePrice TargetRatingAnalyst
    4/25/2024$8.00Buy
    H.C. Wainwright
    8/3/2021$20.00Outperform
    Oppenheimer
    8/2/2021$20.00Outperform
    Oppenheimer
    More analyst ratings

    $PCSA
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chief Business - Strategy Off Lin Patrick converted options into 14,482 shares and covered exercise/tax liability with 4,814 shares, increasing direct ownership by 33% to 38,727 units (SEC Form 4)

      4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)

      4/11/25 5:22:45 PM ET
      $PCSA
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Chief Development Officer Bigora Sian converted options into 15,059 shares and covered exercise/tax liability with 3,311 shares, increasing direct ownership by 54% to 33,626 units (SEC Form 4)

      4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)

      4/11/25 5:17:49 PM ET
      $PCSA
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Chief Administrative Officer Guy Wendy converted options into 14,482 shares, increasing direct ownership by 122% to 26,339 units (SEC Form 4)

      4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)

      4/11/25 5:20:21 PM ET
      $PCSA
      Biotechnology: Pharmaceutical Preparations
      Health Care